ArticleJournal of robotic surgery2026
Adoption of single-port robot-assisted radical prostatectomy following multiport xi experience: lessons from a learning curve analysis.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate whether surgical proficiency acquired with the multiport Xi robotic platform facilitates the early adoption of single-port (SP) robot-assisted radical prostatectomy (RARP). We retrospectively analyzed the first 100 consecutive Xi and the first 100 consecutive SP RARP procedures performed by a single surgeon between March 2020 and July 2026. SP RARP was initiated after completion of the initial 100 Xi procedures. Learning curves were assessed using console-time cumulative sum (CUSUM) analysis with permutation-based change-point testing. Perioperative and pathologic outcomes were compared between platforms. Significant CUSUM change points were identified at case 24 for Xi and case 57 for SP (both P < 0.001). Despite the later SP change point, operative performance was relatively stable from early SP adoption. Median console time (67.0 vs. 97.5 min), operative time (95.0 vs. 145.0 min), and non-console time (28.0 vs. 44.0 min) were shorter with SP (all P < 0.001). Pelvic lymph node dissection was less frequent with SP (1.0% vs. 29.0%, P < 0.001). Thirty-day emergency department visits and readmissions did not differ between groups. Overall positive surgical margin rates were 13.0% with SP and 27.0% with Xi (P = 0.021), whereas stage-stratified rates did not differ significantly. Prior multiport Xi experience facilitated efficient adoption of SP RARP, with relatively short operative times from early SP use despite a later CUSUM change point. These findings suggest that robotic surgical proficiency may be transferable across platforms, while observed differences between platforms should be interpreted in the context of cumulative experience and procedural selection.
Indexed as
Identifiers
42803889What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.